{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:06:36Z","timestamp":1794949596706,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Mycoplasma genitalium<\/jats:italic> (<jats:italic toggle=\"yes\">M. genitalium<\/jats:italic>) and <jats:italic toggle=\"yes\">Trichomonas vaginalis<\/jats:italic> (<jats:italic toggle=\"yes\">T. vaginalis<\/jats:italic>), sexually transmitted infections that remain non-reportable in the United States, may lead to pelvic inflammatory disease (PID) and adverse pregnancy outcomes if left untreated. Prevalence estimates have highlighted socioeconomic and racial\/ethnic disparities in rates of infection. This review summarizes the recent literature on <jats:italic toggle=\"yes\">M. genitalium<\/jats:italic> and <jats:italic toggle=\"yes\">T. vaginalis<\/jats:italic> with a focus on the epidemiology, screening, and treatment of <jats:italic toggle=\"yes\">M. genitalium<\/jats:italic> and <jats:italic toggle=\"yes\">T. vaginalis<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The burden of <jats:italic toggle=\"yes\">T. vaginalis<\/jats:italic> testing remains on women. Antimicrobial resistance is of great concern for <jats:italic toggle=\"yes\">M. genitalium.<\/jats:italic> Comprehensive screening and treatment guidelines present an opportunity to address these public health concerns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">M. genitalium<\/jats:italic> and <jats:italic toggle=\"yes\">T. vaginalis<\/jats:italic> infections disproportionately affect sexual and racial\/ethnic minorities and those facing socioeconomic disparities. The availability of nucleic acid amplification test testing has facilitated accurate diagnosis of both disorders. Safe and efficacious treatments are available for treatment of both disorders. Integrating macrolide resistance testing into treatment algorithms for <jats:italic toggle=\"yes\">M. genitalium<\/jats:italic> and dual antibiotic therapy may prove a useful strategy for future US-based guidance. Public health reporting and increased public awareness campaigns are key next steps to addressing the observed reproductive health disparities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000909","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:26:57Z","timestamp":1591774017000},"page":"482-488","source":"Crossref","is-referenced-by-count":10,"title":["Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections"],"prefix":"10.1097","volume":"32","author":[{"given":"Faye","family":"Korich","sequence":"first","affiliation":[{"name":"Adolescent Medicine, John Hopkins University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha G.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trent","sequence":"additional","affiliation":[{"name":"Adolescent Medicine, John Hopkins University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"issue":"(RR-03)","key":"R1-20230918","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(81)92461-2","article-title":"A newly discovered mycoplasma in the human urogenital tract","volume":"1","author":"Tully","year":"1981","journal-title":"Lancet"},{"key":"R4-20230918","first-page":"319","article-title":"Microbiological and serological study of nongonococcal urethritis with special reference to Mycoplasma genitalium","volume":"61","author":"Taylor-Robinson","year":"1985","journal-title":"Genitourin Med"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/sextrans-2017-053480","article-title":"Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney","volume":"94","author":"Couldwell","year":"2018","journal-title":"Sex Transm Infect"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/cid\/cix853","article-title":"High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama","volume":"66","author":"Dionne-Odom","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/cid\/ciy025","article-title":"A silent epidemic: the prevalence, incidence and persistence of mycoplasma genitalium among young, asymptomatic high-risk women in the United States","volume":"67","author":"Se\u00f1a","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/OLQ.0000000000000874","article-title":"Does the sex risk quiz predict Mycoplasma genitalium infection in urban adolescents and young adult women?","volume":"45","author":"Ronda","year":"2018","journal-title":"Sex Transm Dis"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/sextrans-2017-053367","article-title":"Clinical and sexual risk correlates of Mycoplasma genitalium in urban pregnant and nonpregnant young women: cross-sectional outcomes using the baseline data from the Women's BioHealth Study","volume":"94","author":"Trent","year":"2018","journal-title":"Sex Transm Infect"},{"key":"R13-20230918","year":"2019","journal-title":"FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium"},{"key":"R14-20230918","first-page":"406","article-title":"Molecular testing for mycoplasma genitalium in the United States: results from the AMES prospective multicenter clinical study","volume":"216","author":"Gaydos","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"S802","DOI":"10.1093\/cid\/civ785","article-title":"Efficacy of antimicrobial therapy for Mycoplasma genitalium infections","volume":"61","author":"Manhart","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/0956462419825948","article-title":"British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium","volume":"30","author":"Soni","year":"2019","journal-title":"Int J STD AIDS"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R20-20230918","article-title":"Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability","author":"Durukan","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R21-20230918","first-page":"1","article-title":"Mycoplasma genitalium: a review of current issues and challenges","volume":"62","author":"Manhart","year":"2017","journal-title":"Contemp Ob Gyn"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/OLQ.0b013e31827c08c3","article-title":"A Trich-y question: should Trichomonas vaginalis infection be reportable?","volume":"40","author":"Hoots","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"188.e1","DOI":"10.1016\/j.ajog.2008.10.005","article-title":"Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women","volume":"200","author":"Nye","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/OLQ.0000000000000038","article-title":"Trichomonas vaginalis in selected US sexually transmitted disease clinics: testing, screening, and prevalence","volume":"40","author":"Meites","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/sextrans-2013-051075","article-title":"Global epidemiology of Trichomonas vaginalis","volume":"89","author":"Poole","year":"2013","journal-title":"Sex Transm Infect"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/OLQ.0b013e3181b38a4b","article-title":"Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 national health and nutrition examination surveys","volume":"36","author":"Allsworth","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/511278","article-title":"Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition","volume":"195","author":"McClelland","year":"2007","journal-title":"J Infect Dis"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/OLQ.0000000000000134","article-title":"Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis","volume":"41","author":"Silver","year":"2014","journal-title":"Sex Transm Dis"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.olq.0000179874.76360.ad","article-title":"The prevalence of trichomoniasis in young adults in the United States","volume":"32","author":"Miller","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/OLQ.0000000000000757","article-title":"Screening for Trichomonas vaginalis in a large high-risk population: prevalence among men and women determined by nucleic acid amplification testing","volume":"45","author":"Schwebke","year":"2018","journal-title":"Sex Transm Dis"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cid\/ciy079","article-title":"Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States","volume":"67","author":"Patel","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpag.2010.03.004","article-title":"Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated Nucleic Acid Amplification Test (NAAT): associations with ethnicity, symptoms, and prior and current STIs","volume":"23","author":"Hollman","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/OLQ.0b013e318203e3ce","article-title":"Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations","volume":"38","author":"Roth","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"e01091","DOI":"10.1128\/JCM.01091-17","article-title":"Clinical evaluation of the cepheid Xpert TV assay for detection of Trichomonas vaginalis with prospectively collected specimens from men and women","volume":"56","author":"Schwebke","year":"2018","journal-title":"J Clin Microbiol"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/sextrans-2016-052942","article-title":"Cross-sectional study to evaluate Trichomonas vaginalis positivity in women tested for Neisseria gonorrhoeae and Chlamydia trachomatis, attending genitourinary medicine and primary care clinics in Bristol, South West England","volume":"94","author":"Nicholls","year":"2018","journal-title":"Sex Transm Infect"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S1473-3099(18)30423-7","article-title":"Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial","volume":"18","author":"Kissinger","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMoa003329","article-title":"Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection","volume":"345","author":"Klebanoff","year":"2001","journal-title":"N Engl J Med"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/OLQ.0000000000000902","article-title":"Unexpected high rates of persistent Trichomonas vaginalis infection in a retrospective cohort of treated pregnant women","volume":"46","author":"Lazenby","year":"2019","journal-title":"Sex Transm Dis"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/157488631002150515124548","article-title":"The use of metronidazole during pregnancy: a review of evidence","volume":"10","author":"Sheehy","year":"2015","journal-title":"Curr Drug Saf"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1128\/AAC.06477-11","article-title":"Investigation of metronidazole use during pregnancy and adverse birth outcomes","volume":"56","author":"Koss","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:27:26Z","timestamp":1695004046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000909","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]}}}